Evidence map›Paper›PMID 33815541›Full record

ArticleTanaffos2020

Comparison of Serum Heart-Type Fatty Acid Binding Protein Levels in Stable Chronic Obstructive Pulmonary Disease and Healthy Subjects.

Mohammad Reza Aslani, Hassan Ghobadi, Khadijeh Sarikhani, Saeid Hosseininia, Saeid Sadeghieh-Ahari

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Tanaffos, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mohammad Reza AslaniLung Inflammatory Diseases Research Center, Department of Physiology, Ardabil University of Medical Sciences, Ardabil, Iran.
Hassan GhobadiDepartment of Internal Medicine (Pulmonary Division), School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Khadijeh SarikhaniDepartment of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Saeid HosseininiaDepartment of Internal Medicine (Pulmonary Division), School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Saeid Sadeghieh-AhariDepartment of Community Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Ardabil University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe present study was done to compare serum heart type-fatty acid-binding protein (H-FABP) levels in patients with stable chronic obstructive pulmonary disease (COPD) and healthy subjects and address the correlation of this marker with airflow limitation and health-related quality of life using the COPD assessment test (CAT). MATERIALS AND

methodsIn this cross-sectional study, we measured serum H-FABP levels in 50 patients with stable COPD and 34 healthy controls and compared them in terms of smoking history, airflow limitation according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria, and CAT score. We also tested the association between serum H-FABP level and the COPD patients' clinical parameters. For statistical analysis, we used the Student's t-test, ANOVA, and Pearson's (or Spearman's rank -order) correlation test.

resultsSerum H-FABP level increased in the COPD patients compared with the control group (

conclusionThe serum H-FABP level increased in both the stable COPD patients and healthy subjects with smoking history. However, no correlation was found between serum H-FABP and the severity of airflow limitation based on the GOLD criteria. Based on the results, it is unclear whether the H-FABP level is a causative factor in COPD patients or healthy smokers.

Indexed as

Chronic Obstructive Pulmonary DiseaseCigarette SmokingSerum H-FABP

Identifiers

PMID33815541
PMCPMC8008415
OpenAlexW3151290862

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.